Hemetron

A very professionally organized event with lots of exciting piches! We are very grateful for the selection and the opportunity to extend our collaboration with CSEM! It was a pleasure to pitch on stage and meet the Bio.Incubate community!

The revamped ETH Industry Day format as part of the Open-i is absolutely worth attending! It attracts more visitors, enhances visibility for startups, and fosters better connections.   And offered an interesting twist on the way home…

If you are passionate about healthcare innovation - or you are innovating in healthcare yourself - consider joining Swiss Healthcare Startups! They have built an outstanding community connecting essential players across the ecosystem, from startups and investors to health insurers, caregivers, and beyond.   Representing Hemetron, at the SHS Digital Health Day 2024, Alexander Tanno, PhD enjoyed many dynamic discussions on advancing at-home blood testing, wearables, and AI-driven healthcare solutions and their implementation with MEDKAP Investor Association, Vincent Irrling, Dominik Schürmann, Gilles Lunzenfichter, Olga Nijpels-Tishurova, Thomas Eichmann, and Fabian Balsiger.

Meet us at ETH Industry Day

In 2020, as we embarked on building Hemetron, the onset of the pandemic brought an unexpected twist to our plans. We quickly recognized it as our first opportunity to make a difference, and the team sprang into action. Alexander Tanno, PhD secured the funding, while Yves Blickenstorfer took our first prototype home during the lock-down and perfected the technology on his own. Meanwhile, our newest team member, Vlastimil Jirasko, developed a COVID-19 assay entirely from scratch. When we were finally allowed back into the lab, we collaborated with an exceptional team of students at ETH Zürich and our partners at the University Hospital in Basel. Together, supported by the Basel Research Centre for Child Health, we completed the journey and were able to validate our COVID-19 rapid test using real patient samples in Basel. Our test achieved a sensitivity of 92.1% and a specificity of 96.8%, as recently published in a peer-reviewed scientific journal: https://lnkd.in/dg5WWMWw The experience was transformative for our team, not only in terms of technological advancements, but also in the invaluable lessons we learned. These insights continue to shape our work as we focus on the development of the next and improved generation of our technology. Special thanks to Yves Blickenstorfer, Vlastimil Jirasko, Alexander Tanno, PhD, Sarah Dräger, Darius Hoven, Josephine Loehle Muzen, Stephan Leuch, Yulya Mamedava, Sereina Müller, Karoline Leuzinger, Michael Osthoff, Janos Vörös for the impactful collaboration!